⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16796805 | 1.00 | — | — | |
| SCHEMBL7002111 | 0.84 | — | — | |
| SCHEMBL6599047 | 0.84 | — | — | |
| SCHEMBL6599051 | 0.84 | — | — | |
| SCHEMBL14113110 | 0.81 | — | — | |
| SCHEMBL3446978 | 0.78 | — | — | |
| SCHEMBL5743955 | 0.78 | — | — | |
| SCHEMBL5653171 | 0.78 | — | — | |
| SCHEMBL2071886 | 0.77 | — | — | |
| SCHEMBL3447667 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015087351-A2 | PROCESS FOR THE PREPARATION OF (1S,3S,7S,10R,11S,12S,16R)-7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[(1E)-1-METHYL-2-(2-METHYL-4-THIAZOLYL)ETHENYL]-17-OXA-4-AZABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE AND INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED (IN) | 2015-06-18 | — | — | WO | claimed |
| US-6605726-B1 | Method for producing epothilone B and derivatives, and intermediate products for this method | SCHERING AG (DE) | 2003-08-12 | — | — | US | claimed |
| WO-2015087351-A2 | PROCESS FOR THE PREPARATION OF (1S,3S,7S,10R,11S,12S,16R)-7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[(1E)-1-METHYL-2-(2-METHYL-4-THIAZOLYL)ETHENYL]-17-OXA-4-AZABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE AND INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED (IN) | 2015-06-18 | — | — | WO | disclosed |
| WO-2015087351-A2 | PROCESS FOR THE PREPARATION OF (1S,3S,7S,10R,11S,12S,16R)-7,11-DIHYDROXY-8,8,10,12,16-PENTAMETHYL-3-[(1E)-1-METHYL-2-(2-METHYL-4-THIAZOLYL)ETHENYL]-17-OXA-4-AZABICYCLO[14.1.0]HEPTADECANE-5,9-DIONE AND INTERMEDIATES THEREOF | MSN LABORATORIES PRIVATE LIMITED (IN) | 2015-06-18 | — | — | WO | disclosed |
| US-8435983-B2 | Conformationally restrained epothilone analogues as anti-leukemic agents | THE UNIVERSITY OF TOLEDO (US) | 2013-05-07 | — | — | US | disclosed |
| US-8435983-B2 | Conformationally restrained epothilone analogues as anti-leukemic agents | THE UNIVERSITY OF TOLEDO (US) | 2013-05-07 | — | — | US | disclosed |
| US-8435983-B2 | Conformationally restrained epothilone analogues as anti-leukemic agents | THE UNIVERSITY OF TOLEDO (US) | 2013-05-07 | — | — | US | disclosed |
| US-20110301183-A1 | CHEMICAL SYNTHESIS OF A HIGHLY POTENT EPOTHILONE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-12-08 | — | — | US | disclosed |
| US-20110301183-A1 | CHEMICAL SYNTHESIS OF A HIGHLY POTENT EPOTHILONE | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2011-12-08 | — | — | US | disclosed |
| US-7893268-B2 | Epithiolone analogues | UNIVERSITY OF TOLEDO (US) | 2011-02-22 | — | — | US | disclosed |
| US-20100324094-A1 | Conformationally Restrained Epothilone Analogues as Anti-Leukemic Agents | THE UNIVERSITY OF TOLEDO (US) | 2010-12-23 | — | — | US | disclosed |
| US-6605726-B1 | Method for producing epothilone B and derivatives, and intermediate products for this method | SCHERING AG (DE) | 2003-08-12 | — | — | US | disclosed |
| EP-1282618-A2 | 9-OXA-EPOTHILON DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | Schering Aktiengesellschaft (DE) | 2003-02-12 | — | — | EP | disclosed |
| EP-1121364-B1 | METHOD FOR PRODUCING EPOTHILONE B AND DERIVATIVES THEREOF | SCHERING AG (DE) | 2003-01-08 | — | — | EP | disclosed |
| EP-1150980-A2 | 16-HALOGEN-EPOTHILONE DERIVATIVES, METHOD FOR PRODUCING THEM AND THEIR PHARMACEUTICAL USE | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-11-07 | — | — | EP | disclosed |
| WO-2001081341-A2 | 9-OXA-EPOTHILON DERIVATIVES, METHOD FOR THE PRODUCTION AND USE THEREOF IN PHARMACEUTICAL PREPARATIONS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-11-01 | — | — | WO | disclosed |
| EP-1121364-A1 | METHOD FOR PRODUCING EPOTHILONE B AND DERIVATIVES, AND INTERMEDIATE PRODUCTS FOR THIS METHOD | Schering Aktiengesellschaft (DE) | 2001-08-08 | — | — | EP | disclosed |
| WO-2000049021-A2 | 16-HALOGEN-EPOTHILONE DERIVATIVES, METHOD FOR PRODUCING THEM AND THEIR PHARMACEUTICAL USE | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-08-24 | — | — | WO | disclosed |
| WO-2000049020-A2 | NOVEL EPOTHILON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR PHARMACEUTICAL APPLICATION | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-08-24 | — | — | WO | disclosed |
| WO-2000023452-A1 | METHOD FOR PRODUCING EPOTHILONE B AND DERIVATIVES, AND INTERMEDIATE PRODUCTS FOR THIS METHOD | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-04-27 | — | — | WO | disclosed |